324 related articles for article (PubMed ID: 12482655)
61. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.
Ulane CM; Kentsis A; Cruz CD; Parisien JP; Schneider KL; Horvath CM
J Virol; 2005 Aug; 79(16):10180-9. PubMed ID: 16051811
[TBL] [Abstract][Full Text] [Related]
62. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons.
Pilz A; Ramsauer K; Heidari H; Leitges M; Kovarik P; Decker T
EMBO Rep; 2003 Apr; 4(4):368-73. PubMed ID: 12671680
[TBL] [Abstract][Full Text] [Related]
63. Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect.
Nishio M; Tsurudome M; Ito M; Ito Y
J Virol; 2005 Dec; 79(23):14756-68. PubMed ID: 16282476
[TBL] [Abstract][Full Text] [Related]
64. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha.
Kubota T; Yokosawa N; Yokota S; Fujii N
Biochem Biophys Res Commun; 2001 Apr; 283(1):255-9. PubMed ID: 11322797
[TBL] [Abstract][Full Text] [Related]
65. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
66. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
Basu A; Meyer K; Ray RB; Ray R
Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
68. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
Wang Y; O'Neal KD; Yu-Lee L
Mol Endocrinol; 1997 Aug; 11(9):1353-64. PubMed ID: 9259325
[TBL] [Abstract][Full Text] [Related]
69. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.
Yoneyama M; Suhara W; Fukuhara Y; Fukuda M; Nishida E; Fujita T
EMBO J; 1998 Feb; 17(4):1087-95. PubMed ID: 9463386
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2.
Caignard G; Bouraï M; Jacob Y; ; Tangy F; Vidalain PO
Virology; 2009 Jan; 383(1):112-20. PubMed ID: 19007958
[TBL] [Abstract][Full Text] [Related]
71. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
72. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.
Dupuis S; Jouanguy E; Al-Hajjar S; Fieschi C; Al-Mohsen IZ; Al-Jumaah S; Yang K; Chapgier A; Eidenschenk C; Eid P; Al Ghonaium A; Tufenkeji H; Frayha H; Al-Gazlan S; Al-Rayes H; Schreiber RD; Gresser I; Casanova JL
Nat Genet; 2003 Mar; 33(3):388-91. PubMed ID: 12590259
[TBL] [Abstract][Full Text] [Related]
73. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
[TBL] [Abstract][Full Text] [Related]
74. A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.
Gainey MD; Manuse MJ; Parks GD
J Virol; 2008 Oct; 82(19):9369-80. PubMed ID: 18667520
[TBL] [Abstract][Full Text] [Related]
75. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.
Takeuchi K; Kadota SI; Takeda M; Miyajima N; Nagata K
FEBS Lett; 2003 Jun; 545(2-3):177-82. PubMed ID: 12804771
[TBL] [Abstract][Full Text] [Related]
76. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection.
Ousman SS; Wang J; Campbell IL
J Virol; 2005 Jun; 79(12):7514-27. PubMed ID: 15919906
[TBL] [Abstract][Full Text] [Related]
77. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription.
Lin R; Heylbroeck C; Genin P; Pitha PM; Hiscott J
Mol Cell Biol; 1999 Feb; 19(2):959-66. PubMed ID: 9891032
[TBL] [Abstract][Full Text] [Related]
78. Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins.
Nanda SK; Baron MD
J Virol; 2006 Aug; 80(15):7555-68. PubMed ID: 16840335
[TBL] [Abstract][Full Text] [Related]
79. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.
Yokota S; Yokosawa N; Okabayashi T; Suzutani T; Miura S; Jimbow K; Fujii N
J Virol; 2004 Jun; 78(12):6282-6. PubMed ID: 15163721
[TBL] [Abstract][Full Text] [Related]
80. Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.
Nishio M; Tsurudome M; Ito M; Garcin D; Kolakofsky D; Ito Y
J Virol; 2005 Jul; 79(13):8591-601. PubMed ID: 15956600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
